Engineered immune cells injected directly into the brain to fight childhood tumors

NCT ID NCT04185038

First seen Jan 10, 2026 · Last updated Apr 29, 2026 · Updated 13 times

Summary

This early-stage study tests a new treatment for children and young adults with aggressive brain tumors, including DIPG and other recurrent central nervous system cancers. The therapy uses the patient's own immune cells, which are modified in a lab to recognize and attack tumor cells. These engineered cells are delivered directly into the brain or spinal fluid through a small tube. The main goals are to see if this approach is safe and possible to do, and to learn how the cells move and work in the body.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GLIOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Seattle Children's Hospital

    RECRUITING

    Seattle, Washington, 98105, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

Conditions

Explore the condition pages connected to this study.